https://www.marketscreener.com/quote/stock/INTEGRUM-AB-61747291/news/Clinical-study-of-Integrum-s-OPRA-Implant-System-on-below-knee-amputations-will-include-up-to-30-45295579/?utm_source=telegram&utm_medium=social&utm_campaign=share